HomeInsightsResults

Jagsonpal Pharmaceuticals Ltd Quarterly Result

Jagsonpal Pharmaceuticals Ltd Quarterly Result

stocks purchased

₹ 0.5 Cr

Volume Transacted

(Dec 24, 2024)

stocks purchased

8.5 K

Stocks Traded

(Dec 24, 2024)

Last Updated on: Dec 25, 2024

Image

Jagsonpal Pharmaceuticals Ltd

NSE: JAGSNPHARM

Net Profit

₹ 11.46

Last updated on: Dec 25, 2024

Key Highlights

  • The revenue of Jagsonpal Pharmaceuticals Ltd for the Sep '24 is ₹ 76.35 crore as compare to the Jun '24 revenue of ₹ 62.88 crore. This represent the growth of 21.421751%.
  • The ebitda of Jagsonpal Pharmaceuticals Ltd for the Sep '24 is ₹ 17.94 crore as compare to the Jun '24 ebitda of ₹ 8.4 crore. This represent the growth of 113.57145%.
  • The net profit of Jagsonpal Pharmaceuticals Ltd for the Sep '24 is ₹ 11.46 crore as compare to the Jun '24 net profit of ₹ 5.33 crore. This represent the growth of 115.009384%.

Results Analysis

Market Price of Jagsonpal Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Jagsonpal Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
24 Dec 2024638.9
23 Dec 2024645.8
20 Dec 2024657.8
19 Dec 2024688.05
18 Dec 2024687.25
17 Dec 2024713.2
16 Dec 2024700.75
13 Dec 2024674.5
12 Dec 2024662.6
11 Dec 2024677.8

Historical Revenue of Jagsonpal Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Jagsonpal Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Jagsonpal Pharmaceuticals Ltd

No data available

* All values are in crore

Jagsonpal Pharmaceuticals Ltd News Hub

News

Jagsonpal Pharmaceuticals allots 31,040 equity shares under ESOP

Jagsonpal Pharmaceuticals has allotted 31,040 equity shares under ESOP. Consequently, the ...

Read more

06 Dec 2024 09:48

News

Jagsonpal Pharmaceuticals to table results

Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on ...

Read more

17 Oct 2024 12:13

News

Jagsonpal Pharmaceuticals AGM scheduled

Jagsonpal Pharmaceuticals announced that the 45th Annual General Meeting (AGM) of the comp...

Read more

13 Aug 2024 14:22

News

Jagsonpal Pharmaceuticals declare Quarterly Result

Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on ...

Read more

01 Aug 2024 11:06

News

Jagsonpal Pharmaceuticals completes acquisition of India and Bhutan biz of Yash Pharma

Jagsonpal Pharmaceuticals completed the acquisition of India & Bhutan business of Yash Pha...

Read more

31 May 2024 14:15

News

Board of Jagsonpal Pharmaceuticals recommends final dividend

Jagsonpal Pharmaceuticals announced that the Board of Directors of the Company at its meet...

Read more

21 May 2024 09:56

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Jagsonpal Pharmaceuticals Ltd

What key financial metrics are included in Jagsonpal Pharmaceuticals Ltd's quarterly results?

Key financial metrics in Jagsonpal Pharmaceuticals Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Jagsonpal Pharmaceuticals Ltd announce its quarterly results?

Jagsonpal Pharmaceuticals Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Jagsonpal Pharmaceuticals Ltd's quarterly performance impact its stock price?

Jagsonpal Pharmaceuticals Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Jagsonpal Pharmaceuticals Ltd's quarterly results on dividends?

The impact of Jagsonpal Pharmaceuticals Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Jagsonpal Pharmaceuticals Ltd's quarterly results?

Yes, Jagsonpal Pharmaceuticals Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions